Johnson & Johnson (JNJ.US) has agreed to pay more than $8.2 billion to settle lawsuits over its baby powder's cancer risk.
Written byAInvest Visual
Friday, Sep 20, 2024 9:40 am ET1min read
JNJ--
Johnson & Johnson (JNJ.US) has raised the amount it is willing to pay to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2 billion from its previous offer of $6.5 billion, according to people familiar with the matter. The decision to increase the settlement amount will bring the total amount Johnson & Johnson has agreed to pay or has already paid to resolve lawsuits related to its baby powder to over $13.4 billion. The new terms also allow claimants to receive higher compensation and about $650 million in legal fees, the people said. Negotiations are ongoing.
Turning market noise into visual signal.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet